Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

4 курс / Акушерство и гинекология / Ботвиньева_И_А_Иммунорегуляторные_белки_и_цитокины_при_беременности

.pdf
Скачиваний:
0
Добавлен:
23.03.2024
Размер:
875.82 Кб
Скачать

121

врожденной инфекции у новорожденных с задержкой внутриутробного развития// Акушерство и гинекология. 2013. № 8. С.35-39.

19.Макаров О.В., Бахарева И.В., Ганковская Л.В., Романовская В.В., Ганковская О.А. Toll-подобные рецепторы в генезе невынашивания беременности //Акушерство и гинекология – 2008 - №2- с.22-28.

20.Макаров О.В., Ганковская Л.В., Бахарева И.В., Мезенцева М.В., Кузнецов П.А., Романовская В. В., Магомедова А.М., Ковальчук Л.В. Способ прогнозирования преждевременных родов и внутриутробного инфицирования плода // Патент RU 2486519 от 15.11.2011.

21.Макогон А.В., Вараксин Н.А., Рябичева Т.Г. Уровни цитокинов при синдроме воспалительного ответа у плода //Новости «Вектор-Бест». 2007. № 3 (45). С. 9-12.

22.Макогон А.В., Вараксин Н.А., Андрюшина И.В., Рябичева Т.Г. Изменение профиля цитокинов в зависимости от этиологии синдрома воспалительного ответа у плода // Новости «Вектор-Бест». 2011. № 3 (61). С. 7-12.

23.Малиновская В.В. Виферон – новый противовирусный и иммуномодулирующий препарат // Лечащий врач. 1998. №1. С.34-37.

24.Малиновская В.В. Новый комплексный препарат Виферон и его применение в иммунореабилитации и акушерской практике // International. J. of Immunoreabilitation. 1998. № 10. Р.76-81.

25. Малкова Е.М., Гавалов С.М., Гришаева О.Н. Хламидийная инфекция у новорожденных детей. Кольцово. 2001.- С.3-10.

26.Маркина Л.А., Зорина В.Н., Шрамко С.В., Зорина Р.М., Архипова С.В., Баженова Л.Г. Содержание реактантов воспаления в сыворотке крови женщин при воспалительных заболеваниях придатков матки и участвующих в программе экстракорпора-льного оплодотворения // Клиническая лабораторная диагностика – 2008 - №2 – с.15-17.

122

27.Михнина Е.А. тактика ведения женщин с хламидийной инфекцией в соответствии с современными зарубежными и российскими рекомендациями // материалы 5-й междисциплинарной научно-практической конференции «Урогенитальные инфекции и репродуктивное здоровье: клинико-

 

лабораторная

диагностика»

г.

Санкт-Петербург

10.06.12

 

http://mikhnina.ru/blog/taktika-vedeniya-zhenshhin-s-hlamidiynoy-infektsiey-v- /

28.Ройт А., Бростофф Дж., Мейл Д. Иммунология. М.: Мир, 2000. С. 592.

29.

Рыжикова Л.С., Дружинина Ю.Г., Рябичева Т.Г. и др. Новый набор реагентов

 

для культивирования и митогенной активации клеток цельной крови //

 

Новости «Вектор-Бест». 2009. № 4 (54). С. 8-12.

 

30.

Сидорова И.С., Черниенко И.Н. Внутриутробные инфекции: хламидиоз,

 

микоплазмоз, герпес,

цитомегалия // Рос.вестн. перинатол. – 1998. - № 3. – С.

 

7-13.

 

 

 

 

 

31.

Тареева Т.Г., Малиновская В.В., Шугинин И.О. и др. Система

 

иммунокоррекции

при хронических

инфекционно-воспалительных

 

заболеваниях у беременных // Росс. Вестник акушера-гинеколога. 2004. Т. 4.

№ 5. С. 82-87.

32.Флакс Г.А., Островская П.Ю., Кантин О.М., Корсунская И.М. Влияние урогенитальных инфекций на течение беременности и родов. Журнал

«Трудный пациент» №1-2, 2009, с.17-19

33.Цинзерлинг А.В. Хламидиозы: диагностика, роль в патологии человека //

Арх.патол.- 1989.- Вып. 1. – С.3-9.

34.Ярилин А.А. Иммунология.// М.: Геотар-Медиа, 2010. 752с.

35.Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol. 2005;175:8096–8104.

36.Agrawal T., Vats V., Wallace P., Salhan S., Mittal A. Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-

123

estradiol in development of sequalae to Chlamydia trachomatis infection// Reprod Biol Endocrinol. 2008; 6: 46.

37. Armstrong PB. Proteases and protease inhibitors: a balance of activities in hostpathogen interaction.//Immunobiology. 2006; 211(4): 263-281.

38.Baker E.N., Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin// Cell. Mol. Life Sci. 2005; 62: 2531-2539.

39.Bas.S., muzzin p., vi schor TL. Chlamydia trachomatis serology: diagnostic value of outer membrane pro tein 2 compared with that of other antigens// I.Clin. Micro- biol.-2001.vol.39.-P.4082-5

40.Baud D., Goy G., Jaton K., Osterheld M., Blumer S., Borel N., Vial Y., Hohfeld P., Pospischil A., Greub G. Role of Chlamydia trachomatis in Miscarriage// Emerg Infect Dis. 2011, 17(9): 1630–1635

41.Berlutti F., Pantanella F., Natalizi T., et. al. Antiviral properties of lactoferrin - a natural immunity molecule. //Molecules. 2011; 16(8): 6992-7018.

42.Birkenmeier G. Targetting the proteinase inhibitor and immune modulatory function of human alpha-2-macroglobulin.// Modern. Asp. Immunobiol. 2001; 3: 3236.

43.Bowers E.V., Horvath J.J., Bond J.E., et. al. Antigen delivery by alpha(2)-macro- globulin enhances the cytotoxic T lymphocyte response.// J Leukoc Biol. 2009; 86(5):1259-1268.

44.Budd A., Blandin S., Levashina E.A., Gibson T.J. Bacterial alpha2-macroglobu- lins: colonization factors acquired by horizontal gene transfer from the metazoan genome?// Genome Biol. 2004; 5(6): R38.

45.Carter C.J. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.//Neurosci Lett. 2010; 483(2): 96-100.

46.Chen F, Cheng W, Zhang S, Zhong G, Yu P. Induction of IL-8 by Chlamydia trachomatis through MAPK pathway rather than NF-kappaB pathway.//Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Apr;35(4):307-13.

124

47.Chiabrando, G.A. Vides, M.A Sanchez, M.C. Differential binding properties of human pregnancy zone proteinand alpha2-macroglobulin-proteinase complexes to low-density lipoprotein receptor-related protein. J. Arch. Biochem. Biophys., 2002, 398(1), 73-78.

48.Christian J, Vier J, Paschen SA, Häcker G. Cleavage of the NF-κB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae. //J Biol Chem. 2010 Dec 31;285(53):41320-7.

49.Cunningham K., Stansfield S.H., Patel P., Kienzle V., Allan J.A., Huston W.M. The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection. BMC Immunol. 2013 Nov 15;14(1):50.

50.Daponte A, Pournaras S, Deligeoroglou E, Skentou H, Messinis IE. Serum inter- leukin-1β, interleukin-8 and anti-heat shock 60 Chlamydia trachomatis antibodies as markers of ectopic pregnancy.// J Reprod Immunol. 2012 Mar;93(2):102-8.

51.Darville T, O'Neill JM, Andrews CW, Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol. 2003;171:6187–6197.

52.Dielissen PW, Teunissen DA, Lagro-Janssen TL. Chlamydia prevalence in the general population: is there a sex difference? a systematic review. BMC Infect Dis. 2013 Nov 11;13(1):534.

53.Dieterle S. Chlamydia infections in gynecology and obstetrics // Geburtshilfe. Frauenheilkd. – 1995. – Vol. – 55. - № 9. - P. 510-517.

54.Dimayuga FO, Reed JL, Carnero GA, wang C, Dimayuga ER, Dimayuga VM, Perger A, Wilson ME, Keller JN, Bruce-Keller AJ. Estrogen and brain inflamma-

125

tion: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol. 2005;161:123–136.

55.Dinkla K., Sastalla I., Godehardt A.W., et. al. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.// Microbes Infect. 2007; 9(8): 922-931.

56.Doan N., Gettins P.G. Human alpha2-macroglobulin is composed of multiple domains, as predicted by homology with complement component C3.// Biochem J. 2007; 407(1): 23-30.

57.Doan N., Gettins P.G. alpha-Macroglobulins are present in some gram-negative bacteria: characterization of the alpha2-macroglobulin from Escherichia coli.// J Biol Chem. 2008; 283(42): 28747-28756.

58.Dolmer K., Gettins P.G. Three complement-like repeats compose the complete al- pha2-macroglobulin binding site in the second ligand binding cluster of the low density lipoprotein receptor-related protein.// J Biol Chem. 2006; 281(45): 3418934196.

59.Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, Chavez SL, Romero R, Mor G. Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol. 2007;57:55–66.

60.Franke G.C., Böckenholt A., Sugai M., et. al. Epidemiology, variable genetic organization and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients.// Microbiology. 2010; 156(Pt 3): 860-872.

61.Franciosa G., Maugliani A., Scalfaro C., et. al. Expression of internalin A and biofilm formation among Listeria monocytogenes clinical isolates.//Int J Immunopathol Pharmacol. 2009; 22(1): 183-193.

62.Frazer L.C., Scurlock A.M., Zurenski M.A., Riley M.M., Mintus M., Pociask D.A., Sullivan J.E., Andrews C.W., Darville T. IL-23 Induces IL-22 and IL-17 Production in Response to Chlamydia muridarum Genital Tract Infection, but the

126

Absence of these Cytokines does not Influence Disease Pathogenesis. //Am J Reprod Immunol. 2013 Dec;70(6):472-84.

63.French K., Yerbury J.J., Wilson M.R. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity.// Biochemistry. 2008; 47(4): 1176-1185.

64.Gammazza AM, Bucchieri F, Grimaldi LM, Benigno A, de Macario EC, Macario AJ, Zummo G, Cappello F. The molecular anatomy of human Hsp60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential pathogenetic role of anti-chaperonin immunity in myasthenia gravis. Cell Mol Neurobiol. 2012 Aug; 32(6): 943-7.

65.Gonzalez-Gronow M., Selim M.A., Papalas J., Pizzo S.V. GRP78: a multifunctional receptor on the cell surface.// Antioxid Redox Signal. 2009; 11(9): 22992306.

66.Haar K., Bremer V., Houareau C., Meyer T., Desai S., Thamm M., Hamouda O. Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006.// Euro Surveill. 2013 Aug 22;18(34). pii: 20562

67.Haggerty C.L., Klebanoff M.A., Uldum S.A., Bass D.C., Olsen J., Roberts J.M., Ness R.B. Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia Pregnancy Hypertens 2013 Jul 1;3(3):151-154.

68.Hajikhani B Motallebi T Norouzi J Bahador A Bagheri R Asgari S ChamaniTabriz L. Classical and Molecular Methods for Evaluation of Chlamydia trachomatis Infection in Women with Tubal Factor Infertility.//J Reprod Infertil. 2013 Jan;14(1):29-33.

69.Hall JV, Schell M, Dessus-Babus S, Moore CG, Whittimore JD, Sal M, Dill BD, Wyrick PB. The multifaceted role of oestrogen in enhancing Chlamydia trachomatis infection in polarized human endometrial epithelial cells.// Cell Microbiol. 2011 Aug;13(8):1183-99.

127

70.Hernandez-Trejo M, Herrera-Gonzalez NE, Escobedo-Guerra MR, de Haro-Cruz MD, Moreno-Verduzco ER, Lopez-Hurtado M, Guerra-Infante FM. Reporting detection of Chlamydia trachomatis DNA in tissues of neonatal death cases. J Pediatr (Rio J). 2013 Oct 30. pii: S0021-7557(13)00201-5.

71.Hjelholt A , Christiansen G , Johannesson TG , Ingerslev HJ , Birkelund S . Tubal factor infertility is associated with antibodies against Chlamydia trachomatis heat shock protein 60 (HSP60) but not human HSP60. Hum Reprod. 2011 Aug;26(8):2069-76.

72.Howie S.E., Horner P.J., Horne A. Chlamydia trachomatis infection during pregnancy – known unknowns.// Discov Med. – 2011. – Vol.12(62). – p.57-64.

73.Hoyme U.B. Chlamydia infection and salpingitis // Zentralbl. Gynacol.-1992.-Vol. 114.- № 11.- P. 525-532.

74.Hueston W.J., Lenhart J.G., A decision analysis to guide antibioticselection for Chlamydia infection during pregnancy. // Arch.Fam.Med -1997, 6(6): 551-555.

75.Huson L.E., Authie E., Boulange A.F., et. al. Modulation of the immunogenicity of the Trypanosoma congolense cysteine protease, congopain, through complexation with alpha(2)-macroglobulin.// Vet Res. 2009; 40(6): 52.

76.Ikeme A.C., Ezegwui H.U., Ikeako L.C., Agbata I., Agbata E. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria.// Niger J Clin Pract. 2011 Apr- Jun;14(2):176-80.

77.Jalal H, Delaney A, Bentley N, Sonnex C, Carne CA Molecular epidemiology of selected sexually transmitted infections// Int J Mol Epidemiol Genet. 2013 Sep 12;4(3):167-74.

78.Kantyka T., Rawlings N.D., Potempa J. Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.// Biochimie. 2010; 92(11): 1644-1656.

79.Kavathas P.B., Boeras C.M., Mulla M.J., Abrahams V.M. Nod1, but not the ASC inflammasome, contributes to induction of IL-1β secretion in human trophoblasts

128

after sensing of Chlamydia trachomatis.// Mucosal. Immunol. 2013 Mar;6(2):23543.

80.Kolodziej S.J., Klueppelberg H.U., Nolasco N., Ehses W., Strickland D.K., Stoops J.K. Three-dimensional structure of the human plasmin alpha2-macroglobulin complex. J. Struct. Biol., 1998, 123(2), 124-133.

81.Kuzanovic J.P., Romero R., Mazaki-Tovi S. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation// J. Matern. Fetal. Neonatal. Med. 2008. V. 21. N. 12. P. 902-916.

82.Legrand D., Elass E., Carpenter M., Mazurer J. Lactoferrin: a modulator of immune and inflammatory responses// Cell. Mol. Life Sci. 2005; 62: 2549-2559.

83.Majeroni B.A. Chlamydial cervicitis: complication and treatment options // Am. Fam.Physician. - 1994. - Vol. 49. - № 8. - P. 1825-1829.

84.Merrill E., Crowle A.J. Crossed immunoelectrophoresis: qua-litative and quantitative considerations. J.Immunol.Meth., 1982, 50, R65-R83.

85.Michou IV Constantoulakis P Makarounis K Georgoulias G Kapetanios V, Tsilivakos V Molecular investigation of menstrual tissue for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis collected by women with a history of infertility. J Obstet Gynaecol Res. 2013 Oct 7. doi: 10.1111/jog.12165.

86.Miller J.M., Martin D.H. Treatment of Chlamydia trachomatis infections in pregnant women // Drugs. – 2000. – Vol. 60. - № 3. – P. 597-605.

87.Mirza S., Wilson L., Benjamin W.H. Jr., et. al. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.// Infect Immun. 2011; 79(6): 2440-2450.

88.Moore A.R., Appelboam A., Kawabata K, Da Silva J.A., D'Cruz D., Gowland G., Willoughby D.A. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis. Ann. Rheum. Dis., 1999, 58(2), 109113.

129

89.Mpiga P, Mansour S, Morisset R, Beaulieu R, Ravaoarinoro M. Sustained inter- leukin-6 and interleukin-8 expression following infection with Chlamydia trachoamtis serovar L2 in a HeLa/THP-1 cell co-culture model. Scand J Immunol. 2006;63:199–207.

90.Osman I., Young A., Ledingham M. et al. Leukocyte density and proinfl ammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term // Mol. Hum. Reprod. 2003. V. 9. № 1. Р. 41-45.

91.Petersen C.M. Alpha-2-macroglobulin and pregnancy zone protein. Serum level, alpha-2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology// Dan.Med.Bull. - 1993. - V. 40. - p. 409-446.

92.Puddu P., Latorre D., Carollo M., et. al. Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells.// PLoS One. 2011; 6(7): e22504.

93.Rastogi S., Kapur S., Salhan S. et al. Chlamydia trachomatis infection in pregnancy: Risk factor for an adverce outcome. // Brit.J.Biomed.Scien. 1999. 56:94-98 94.Robertson S.A., Skinner R.J., Care A.S. Essential role for interleukin-10 in resistance to LPS-induced preterm labour in mice // J. Immunol. 2006. V. 177. P. 4888-

4896.

95.Rours G.I.J.G., Duijts L.,Moll H.A., Arends L.R., de Groot R., Jaddoe V.W., Hofman A., Steegers E.A.P., Mackenbach J.P., Ott A., Willemse H.F.M., van der Zwaan E.A.E., Verkooijen R.P., Verbrugh H.A. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study Eur J Epidemiol. 2011; 26(6): 493–502.

96.Rours G.I.J.G., Duijts L.,Moll H.A., Arends L.R., de Groot R., Jaddoe V.W., Hofman A., Steegers E.A.P., Mackenbach J.P., Ott A., Willemse H.F.M., van der Zwaan E.A.E., Verkooijen R.P., Verbrugh H.A. Chlamydia trachomatis infection

130

during pregnancy associated with preterm delivery: a population-based prospective cohort study Eur J Epidemiol. 2011; 26(6): 493–502.

97.Scharfstein J. Parasite cysteine proteinase interactions with alpha 2-macroglobulin or kininogens: differential pathways modulating inflammation and innate immunity in infection by pathogenic trypanosomatids.// Immunobiology. 2006; 211(1- 2): 117-125.

98.Shariat H., Young M., Abedin M. An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia // J. Perinatol. – 1992. – Vol. – 12. - № 3. – P. 300-302.

99.Shaw E., Roberts D., Connor P.D. Prevalence of and risk factors for Chlamydia in a rural pregnant population // J. Fam. Pract. – 1995. – Vol. 41. - № 3. – P/ 257260.

100.Smith D.C., Spooner R.A., Watson P.D., et. al. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum.// Traffic. 2006; 7(4): 379-393.

101.Sollecito D., Midulla M., Bavastrelli M. et al. Chlamydia trachomatis in neonatal respiratory distress of very preterm babies:biphasic clinical picture // ActaPaediatr. – 1992. – Vol. 81. - № 10. – P. 788-791.

102.Speer E.M., Gentile D.A., Zeevi A. et al. // Hum. Immunol. 2006. V. 67. P. 915-923.

103.Srivastava P, Bhengraj AR, Jha HC, Vardhan H, Jha R, Singh LC, Salhan S, Mittal A. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.// DNA Cell Biol. 2012 Mar;31(3):392-401.

104.Stief T.W., Kropf J., Kretschmer V., Doss M.O., Fareed J. Singlet oxygen ((1)O2) inactivates plasmatic free and complexed alpha2-macroglobulin. Thromb Res., 2000, 98(6), 541-547